Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Rated 4.90 out of 5 based on 10 customer ratings (10 customer reviews) Original price was: 479.Current price is: 453
A phase 1 study of LY4101174 (ETx-22), an antibody-drug conjugate targeting nectin-4, in patients with advanced or metastatic urothelial cancer and other solid tumors (trial in progress)
Structural and functional fine mapping of cysteines in mammalian glutaredoxin reveal their differential oxidation susceptibility
Key Product Characteristics: Maximum Strength Therapeutic Payload: The 15mg dose offers the highest standardized clinical concentration for sustained, long-term maintenance of metabolic equilibrium and weight loss plateau mitigation
TBI could be of forms, i.e., primary and secondary phases of damages (Ye et al., 2023)
US$ 23.58
US$ 27.81
US$ 23.18
US$ 27.90
US$ 23.93
US$ 21.01
